127 related articles for article (PubMed ID: 6608216)
1. Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation.
Zídek Z; Masek K; Sedivý F
Agents Actions; 1984 Jan; 14(1):72-5. PubMed ID: 6608216
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of LPS, MDP and FMLP on carrageenan pleurisy in the rat.
Allen CA; Ferry DM; Chadwick VS
Agents Actions; 1994 Mar; 41(1-2):53-6. PubMed ID: 8079822
[TBL] [Abstract][Full Text] [Related]
3. Degradation of muramyl dipeptide by mammalian serum.
Harrison J; Fox A
Infect Immun; 1985 Oct; 50(1):320-1. PubMed ID: 3876287
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
[TBL] [Abstract][Full Text] [Related]
5. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.
Phillips NC; Chedid L
Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001
[TBL] [Abstract][Full Text] [Related]
6. Some cellular and pathophysiological correlates of the inflammatory effects of a synthetic immunomodulatory agent, muramyl dipeptide (MDP).
Zídek Z; Franková D; Masek K
Agents Actions; 1993 Jan; 38(1-2):106-15. PubMed ID: 8386899
[TBL] [Abstract][Full Text] [Related]
7. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
8. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
9. Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.
Zídek Z
Agents Actions; 1992 May; 36(1-2):136-45. PubMed ID: 1414682
[TBL] [Abstract][Full Text] [Related]
10. Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide.
Zídek Z; Maśek K; Jiricka Z
Infect Immun; 1982 Feb; 35(2):674-9. PubMed ID: 6976939
[TBL] [Abstract][Full Text] [Related]
11. Multiplicity of biological effects of muramyl dipeptide.
Masek K
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):97-9. PubMed ID: 3713377
[TBL] [Abstract][Full Text] [Related]
12. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
14. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
16. Hepatic mixed-function oxidase system and microsomal lipid peroxidation in rats treated with a synthetic immunomodulator, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Yanev S; Zídek Z; Kadiiska M; Serbinova E; Masek K; Stoytchev T
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):311-5. PubMed ID: 6748821
[TBL] [Abstract][Full Text] [Related]
17. Edemagenic activity of aqueous form of muramyl dipeptide (MDP) in rats.
Zídek Z; Masek K
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):419-26. PubMed ID: 4079592
[TBL] [Abstract][Full Text] [Related]
18. Lack of immunostimulatory effect of N-acetyl muramyl-L-alanyl-D-isoglutamine on selected chicken immune functions.
Neumann U; Wischner H; Siegmann O
Comp Immunol Microbiol Infect Dis; 1982; 5(4):413-21. PubMed ID: 7172620
[TBL] [Abstract][Full Text] [Related]
19. Marked enhancement of macrophage activation induced by synthetic muramyl dipeptide (MDP) conjugate using monoclonal anti-MDP antibodies.
Leclerc C; Bahr GM; Chedid L
Cell Immunol; 1984 Jul; 86(2):269-77. PubMed ID: 6733783
[TBL] [Abstract][Full Text] [Related]
20. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
